Accretive Health, Inc.

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Q: Jun 30 2021

Q: Mar 31 2021

FY: Dec 31 2020

Q: Sep 30 2020

Q: Jun 30 2020

Q: Mar 31 2020

FY: Dec 31 2019

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

FY: Dec 31 2018

Q: Sep 30 2018

Q: Jun 30 2018

Q: Mar 31 2018

FY: Dec 31 2017

Q: Sep 30 2017

Q: Jun 30 2017

1.01,1.02,2.01,2.03,3.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01

5.02,9.01

5.07

8.01

2.02,7.01,9.01

5.02

2.02,7.01,9.01

5.02,7.01,9.01

9.01

1.01,2.02,7.01,8.01,9.01

7.01,9.01

2.02,9.01

5.02,7.01,9.01

2.02,9.01

1.01,1.02,2.03,9.01

1.01,3.02,9.01

5.02,5.07,9.01

7.01,9.01

2.02,9.01

1.01,8.01,9.01

Certification of termination of registration of a class of securities (Section 12(g))

Notification of removal from listing and/or registration on a national securities exchange

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Additional Information for Proxy Statement/ Votes

No description available

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Smith Jill D.

Feiner Michael C.

ZIMMERLI ALBERT RENE

Bundy Scanlan Agnes

FLANAGAN JOSEPH GERARD

Speranzo Anthony J

WILSON RACHEL

TERSIGNI ANTHONY R

Evans Richard B. Jr.

HENNEMAN JOHN B III

DILL DAVID M

SPARBY JOHN M.

LONG GARY STEVEN

none

MOSZKOWSKI NEAL

Feiner Michael C.

Bundy Scanlan Agnes

HENNEMAN JOHN B III

Smith Jill D.

TERSIGNI ANTHONY R

Post-effective amendment to an automatic shelf registration statement

No description available

No description available

No description available

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

No description available

No description available

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

No description available

No description available